Hepatic inositol 1,4,5 trisphosphate receptor type 1 mediates fatty liver

Fatty liver is the most common type of liver disease, affecting nearly one third of the U.S. population and more than half a billion people worldwide. Abnormalities in endoplasmic reticulum (ER) calcium handling and mitochondrial function each have been implicated in abnormal lipid droplet formation. Here we show that the type 1 isoform of the inositol 1,4,5‐trisphosphate receptor (InsP3R1) specifically links ER calcium release to mitochondrial calcium signaling and lipid droplet formation in hepatocytes. Moreover, liver‐specific InsP3R1 knockout mice have impaired mitochondrial calcium signaling, decreased hepatic triglycerides, and reduced lipid droplet formation and are resistant to the development of fatty liver. Patients with nonalcoholic steatohepatitis, the most malignant form of fatty liver, have increased hepatic expression of InsP3R1, and the extent of ER–mitochondrial colocalization correlates with the degree of steatosis in human liver biopsies. Conclusion: InsP3R1 plays a central role in lipid droplet formation in hepatocytes, and the data suggest that it is involved in the development of human fatty liver disease. (Hepatology Communications 2017;1:23–35)

[1]  L. Henry,et al.  Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.

[2]  J. Shelton,et al.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver. , 2015, The Journal of clinical investigation.

[3]  A. P. Arruda,et al.  Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes. , 2015, Cell metabolism.

[4]  G. Barritt,et al.  Steatosis inhibits liver cell store-operated Ca²⁺ entry and reduces ER Ca²⁺ through a protein kinase C-dependent mechanism. , 2015, The Biochemical journal.

[5]  G. Shulman,et al.  Inositol 1,4,5-trisphosphate receptor type II (InsP3R-II) is reduced in obese mice, but metabolic homeostasis is preserved in mice lacking InsP3R-II. , 2014, American journal of physiology. Endocrinology and metabolism.

[6]  Edward S. Allgeyer,et al.  Apical Localization of Inositol 1,4,5-Trisphosphate Receptors Is Independent of Extended Synaptotagmins in Hepatocytes , 2014, PloS one.

[7]  Güneş Parlakgül,et al.  Chronic enrichment of hepatic endoplasmic reticulum–mitochondria contact leads to mitochondrial dysfunction in obesity , 2014, Nature Medicine.

[8]  A. McCullough,et al.  Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients☆ , 2014, BBA clinical.

[9]  G. Shulman.  Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. , 2014, The New England journal of medicine.

[10]  Jamey D. Young,et al.  ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload , 2014, Molecular metabolism.

[11]  Anne Tybjærg-Hansen,et al.  Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.

[12]  Jing Zhang,et al.  Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis. , 2014, American journal of physiology. Cell physiology.

[13]  R. Resende,et al.  The insulin receptor translocates to the nucleus to regulate cell proliferation in liver , 2014, Hepatology.

[14]  A. Choi,et al.  Mitochondrial Dysfunction Induces Formation of Lipid Droplets as a Generalized Response to Stress , 2013, Oxidative medicine and cellular longevity.

[15]  P. Meikle,et al.  Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding , 2013, Diabetologia.

[16]  Dean P. Jones,et al.  Endoplasmic reticulum stress in nonalcoholic fatty liver disease. , 2012, Annual review of nutrition.

[17]  J. Yates,et al.  Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. , 2012, Cell metabolism.

[18]  G. Shulman,et al.  Dissociation of Inositol-requiring Enzyme (IRE1α)-mediated c-Jun N-terminal Kinase Activation from Hepatic Insulin Resistance in Conditional X-box-binding Protein-1 (XBP1) Knock-out Mice* , 2011, The Journal of Biological Chemistry.

[19]  S. Gautam,et al.  Type 2 inositol 1,4,5‐trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes , 2011, Hepatology.

[20]  Yongxin Zhao,et al.  An Expanded Palette of Genetically Encoded Ca2+ Indicators , 2011, Science.

[21]  R. Resende,et al.  Mitochondrial calcium regulates rat liver regeneration through the modulation of apoptosis , 2011, Hepatology.

[22]  Kenneth W Dunn,et al.  A practical guide to evaluating colocalization in biological microscopy. , 2011, American journal of physiology. Cell physiology.

[23]  Lee H. Dicker,et al.  Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity , 2011, Nature.

[24]  S. Park,et al.  Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity , 2010, Proceedings of the National Academy of Sciences.

[25]  Gregory J Morton,et al.  Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice , 2010, Disease Models & Mechanisms.

[26]  Jeremy Adler,et al.  Quantifying colocalization by correlation: The Pearson correlation coefficient is superior to the Mander's overlap coefficient , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[27]  A. Mennone,et al.  Regulation of multidrug resistance‐associated protein 2 by calcium signaling in mouse liver , 2010, Hepatology.

[28]  C. Fernandes‐Santos,et al.  A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet , 2010, Journal of clinical biochemistry and nutrition.

[29]  P. Pinton,et al.  Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis , 2008, Oncogene.

[30]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[31]  M. Leite,et al.  Nucleoplasmic Calcium Is Required for Cell Proliferation* , 2007, Journal of Biological Chemistry.

[32]  J. Dranoff,et al.  The Spatial Distribution of Inositol 1,4,5-Trisphosphate Receptor Isoforms Shapes Ca2+ Waves* , 2007, Journal of Biological Chemistry.

[33]  Takeshi Sakaba,et al.  The Coupling between Synaptic Vesicles and Ca2+ Channels Determines Fast Neurotransmitter Release , 2007, Neuron.

[34]  B. Ehrlich,et al.  Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[35]  M. Trevisan,et al.  Body Fat Distribution, Liver Enzymes, and Risk of Hypertension: Evidence From the Western New York Study , 2005, Hypertension.

[36]  U. John,et al.  Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. , 2005, World journal of gastroenterology.

[37]  L. Glimcher,et al.  Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.

[38]  J. Martinou,et al.  Ca2+ Homeostasis during Mitochondrial Fragmentation and Perinuclear Clustering Induced by hFis1*[boxs] , 2004, Journal of Biological Chemistry.

[39]  R. Rizzuto,et al.  Mitochondrial Ca2+ Uptake Requires Sustained Ca2+ Release from the Endoplasmic Reticulum* , 2003, The Journal of Biological Chemistry.

[40]  P. Koulen,et al.  Nuclear and cytosolic calcium are regulated independently , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  J. Dranoff,et al.  The type II inositol 1,4,5-trisphosphate receptor can trigger Ca2+ waves in rat hepatocytes. , 2002, Gastroenterology.

[42]  M. Berridge,et al.  Functional InsP3 receptors that may modulate excitation–contraction coupling in the heart , 2000, Current Biology.

[43]  G. Rutter,et al.  Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Kenzo Hirose,et al.  Encoding of Ca2+ signals by differential expression of IP3 receptor subtypes , 1999, The EMBO journal.

[45]  Lawrence M. Lifshitz,et al.  Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. , 1998, Science.

[46]  Keli Xu,et al.  Calcium oscillations increase the efficiency and specificity of gene expression , 1998, Nature.

[47]  L. Feng,et al.  The role of intracellular Ca2+ in the regulation of gluconeogenesis. , 1996, Metabolism: clinical and experimental.

[48]  K. Mikoshiba,et al.  Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor , 1996, Nature.

[49]  György Hajnóczky,et al.  Decoding of cytosolic calcium oscillations in the mitochondria , 1995, Cell.

[50]  R. Wojcikiewicz,et al.  Type I, II, and III inositol 1,4,5-trisphosphate receptors are unequally susceptible to down-regulation and are expressed in markedly different proportions in different cell types , 1995, The Journal of Biological Chemistry.

[51]  E J Sass,et al.  Characterization of cytosolic calcium oscillations induced by phenylephrine and vasopressin in single fura-2-loaded hepatocytes. , 1989, The Journal of biological chemistry.

[52]  T. Chan,et al.  Studies on alpha-adrenergic activation of hepatic glucose output. , 1978, The Journal of biological chemistry.

[53]  P. Blackmore,et al.  Studies on alpha-adrenergic activation of hepatic glucose output. Studies on role of calcium in alpha-adrenergic activation of phosphorylase. , 1977, The Journal of biological chemistry.

[54]  M. Nathanson,et al.  Calcium signaling in the liver. , 2013, Comprehensive Physiology.

[55]  L. N. Valenti,et al.  Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[56]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.